[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Prostate Cancer Drugs Market Research Report Forecast 2017-2021

May 2017 | 128 pages | ID: C06DE532D05EN
S&P Consulting

US$ 2,480.00 US$ 3,100.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The China Prostate Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prostate Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prostate Cancer Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer

China Prostate Cancer Drugs Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Prostate Cancer Drugs Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 PROSTATE CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Market Segmentation by Type
  1.2.1 China Production Market Share of Prostate Cancer Drugs by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prostate Cancer Drugs Market Segmentation by Application
  1.3.1 Prostate Cancer Drugs Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Prostate Cancer Drugs (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON PROSTATE CANCER DRUGS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Prostate Cancer Drugs Industry

CHAPTER 3 CHINA PROSTATE CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 China Prostate Cancer Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 China Prostate Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Prostate Cancer Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Prostate Cancer Drugs Market Competitive Situation and Trends
  3.5.1 Prostate Cancer Drugs Market Concentration Rate
  3.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA PROSTATE CANCER DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Prostate Cancer Drugs Capacity, Production and Growth (2012-2017)
4.2 China Prostate Cancer Drugs Revenue and Growth (2012-2017)
4.3 China Prostate Cancer Drugs Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA PROSTATE CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Prostate Cancer Drugs Production and Market Share by Type (2012-2017)
5.2 China Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Prostate Cancer Drugs Price by Type (2012-2017)
5.4 China Prostate Cancer Drugs Production Growth by Type (2012-2017)

CHAPTER 6 CHINA PROSTATE CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Prostate Cancer Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA PROSTATE CANCER DRUGS MANUFACTURERS ANALYSIS

7.1 Bristol-Myers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 AstraZeneca
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 GSK
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Novartis
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Pfizer
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Sanofi
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Bayer
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Prostate Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostate Cancer Drugs

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Prostate Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA PROSTATE CANCER DRUGS MARKET FORECAST (2017-2021)

12.1 China Prostate Cancer Drugs Production, Revenue Forecast (2017-2021)
12.2 China Prostate Cancer Drugs Production, Consumption Forecast by Regions (2017-2021)
12.3 China Prostate Cancer Drugs Production Forecast by Type (2017-2021)
12.4 China Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)
12.5 Prostate Cancer Drugs Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Figure China Production Market Share of Prostate Cancer Drugs by Type 1n 2016
Table Prostate Cancer Drugs Consumption Market Share by Application in 2016
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Table China Prostate Cancer Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Prostate Cancer Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Prostate Cancer Drugs Capacity of Key Manufacturers in 2015
Figure China Prostate Cancer Drugs Capacity of Key Manufacturers in 2016
Table China Prostate Cancer Drugs Production of Key Manufacturers (2015 and 2016)
Table China Prostate Cancer Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Production Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Production Share by Manufacturers
Table China Prostate Cancer Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 China Prostate Cancer Drugs Revenue Share by Manufacturers
Table China Market Prostate Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Prostate Cancer Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Drugs Product Type
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Prostate Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Prostate Cancer Drugs Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Prostate Cancer Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Prostate Cancer Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Prostate Cancer Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Prostate Cancer Drugs Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Prostate Cancer Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Prostate Cancer Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prostate Cancer Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Prostate Cancer Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Prostate Cancer Drugs Market Share (2012-2017)
Figure Production Revenue Share of Prostate Cancer Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Prostate Cancer Drugs by Type
Table China Prostate Cancer Drugs Price by Type (2012-2017)
Figure China Prostate Cancer Drugs Production Growth by Type (2012-2017)
Table China Prostate Cancer Drugs Consumption by Application (2012-2017)
Table China Prostate Cancer Drugs Consumption Market Share by Application (2012-2017)
Figure China Prostate Cancer Drugs Consumption Market Share by Application in 2015
Table China Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure China Prostate Cancer Drugs Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table China Prostate Cancer Drugs Production, Import, Export and Consumption Forecast (2017-2021)
Table China Prostate Cancer Drugs Production Forecast by Type (2017-2021)
Table China Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene


More Publications